Amalgamated Bank reduced its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 3.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 115,870 shares of the financial services provider’s stock after selling 4,088 shares during the period. Amalgamated Bank’s holdings in MetLife were worth $9,557,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. National Bank of Canada FI lifted its position in shares of MetLife by 54.9% during the 1st quarter. National Bank of Canada FI now owns 371,062 shares of the financial services provider’s stock worth $26,983,000 after buying an additional 131,538 shares during the last quarter. PFG Investments LLC grew its holdings in shares of MetLife by 8.9% during the 3rd quarter. PFG Investments LLC now owns 6,360 shares of the financial services provider’s stock valued at $525,000 after purchasing an additional 520 shares during the last quarter. Acadian Asset Management LLC acquired a new position in MetLife during the 1st quarter worth approximately $1,053,000. Entropy Technologies LP lifted its stake in MetLife by 38.3% in the 1st quarter. Entropy Technologies LP now owns 30,473 shares of the financial services provider’s stock valued at $2,258,000 after purchasing an additional 8,440 shares during the last quarter. Finally, M&G Plc acquired a new stake in MetLife in the second quarter valued at approximately $2,346,000. 89.81% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of brokerages have recently commented on MET. Morgan Stanley dropped their price target on MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a research note on Monday, August 19th. Piper Sandler lifted their price target on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a research note on Friday, October 4th. TD Cowen initiated coverage on shares of MetLife in a research report on Wednesday, October 9th. They set a “buy” rating and a $97.00 target price on the stock. Finally, Barclays dropped their price target on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a research note on Thursday, October 31st. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $88.46.
MetLife Trading Up 0.2 %
MET opened at $78.15 on Wednesday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.49. The company has a fifty day moving average price of $80.73 and a two-hundred day moving average price of $75.03. The company has a market cap of $54.73 billion, a P/E ratio of 15.76, a price-to-earnings-growth ratio of 0.71 and a beta of 1.05. MetLife, Inc. has a 1-year low of $58.89 and a 1-year high of $86.94.
MetLife Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be issued a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.79%. The ex-dividend date is Tuesday, November 5th. MetLife’s dividend payout ratio is currently 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- Energy and Oil Stocks Explained
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Airline Stocks – Top Airline Stocks to Buy Now
- Insider Buying Signals Upside for These 3 Stocks
- Investing in Travel Stocks Benefits
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.